Products and Resources Catalog

After attending this webinar from Dr. Sheryl Ryan, viewers should be able to: 1. Describe the biology of cannabis products and the endocannabinoid system. 2. Explain the adverse short and long-term health effects of cannabis products especially during pregnancy and breast-feeding on fetal and neonatal development. 3. Discuss prevention strategies including multi-sector approaches and recommendations for people who are pregnant, planning pregnancy, or breastfeeding. Slide Deck Available: Here

  This document provides information on xylazine, a non-opioid veterinary tranquilizer used as an additive in illicit drug supplies, notably in combination with heroin and fentanyl. It discusses the effects of xylazine use, including sedation and potential risks such as hypotension and bradycardia. The document also emphasizes harm reduction interventions for individuals who may encounter xylazine in the drug supply, including the use of naloxone for responding to overdoses and the importance of wound identification and treatment.

The September 2023 Dialogue contains articles on: Addiction: Nurturing Purpose in Recovery: Unveiling Passions and Living Intentionally | Mental Health: Improving Suicide Prevention Strategies in Maryland | Prevention: Improving Suicide Prevention Strategies in Maryland | ORN: Addressing Regional Needs Additional sections include behavioral health observances, virtual training and webinar events, Region 3 news, and new resources. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated on the first Tuesday of each month. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter.  Sign up to receive the Dialogue in your mailbox. 

The Northeast and Caribbean Summer 2023 Newsletter (English | Spanish) is here. This issue highlights resources for professionals in academic settings and parents, as well as, our upcoming trainings.   

Webinar Description This training looked at the importance of Data Informed Decision Making, or DIDM, in strategic prevention planning, and the value of using data within each step of the Strategic Prevention Framework (SPF) to identify priority needs and achieve prevention goals. During this webinar, presenters defined key data-related terminology, described the benefits of using a data-informed prevention planning process, discussed common challenges and barriers to using data to plan and examined data-informed decision making within each SPF step.   Presenter Emily Bhargava is a Training and Technical Assistance Associate with Education Development Center (EDC). She is skilled in facilitation, data literacy, strategic and sustainability planning, and evaluation design. For over 15 years, she has led community-level health promotion efforts. She is an expert in the prevention of substance abuse, violence, suicide, teen pregnancy, obesity, and HIV, guiding the planning and implementation of culturally and linguistically responsive community-level prevention and health promotion efforts across Massachusetts and the United States.   Additional Resources  Flyer  PowerPoint

In this Issue:   *New South Southwest PTTC Prevention Onboarding Roadmap Other PTTC Resources for Onboarding the New Prevention Professional Epi Corner: Using a Multi-faceted Approach to Adolescent Opioid Misuse and Overdose What's Happening Around the Region?

This product is developed by Cheyenne Chee under the 2022-2023 Mountain Plains Prevention Technology Transfer Center (PTTC) Fellowship Program. This toolkit is designed to provide Native American parents/ guardians with valuable resources and information to prevent cannabis use among youth. By utilizing the PTTC Network and Gray Matters campaign as primary resources, this toolkit aims to empower parents/guardians in promoting healthy choices and supporting their children's well-being. Additional relevant resources are also included to enhance the effectiveness of prevention efforts. 

This product is developed by Morgan Neavill, M.S. under the 2022-2023 Mountain Plains Prevention Technology Transfer Center (PTTC) 2022-23 Fellowship Program. Are you interested in advocating for the health and wellbeing of Montanans, but not sure where to begin? This toolkit will give you an overview of what it means to advocate on the issue of marijuana, and how to do so effectively. Montana Alliance of Prevention Website

Xylazine: Understanding the Latest Emerging Substance July 25, 2023, 1:00pm-3:00pm EST COURSE DESCRIPTION Xylazine (or “tranq”) is a non-opioid sedative and tranquilizer only approved for use in veterinary medicine. However, over the past several years, human consumption of xylazine has begun rapidly increasing. Although initially only identified in illicit drug supplies in limited areas, xylazine has been found in 48 states as of April 2023. Xylazine is frequently, though not exclusively, used in conjunction with opioids, particularly fentanyl—due to xylazine’s ability to prolong their effects. Xylazine use presents many potential dangers to people, including increased risk of overdose and the development of necrotizing tissue damage. This webinar will bring together experts from across disciplines to discuss the history of xylazine use, what is known about its current scope of use and consequences, the effects of xylazine on people, and wound care and other harm reduction strategies. It will also offer an opportunity for participants to ask questions in a roundtable panel discussion format. LEARNING OBJECTIVES Describe Xylazine and its history of use and consequences. Explain how harm reduction strategies need to be adapted for complications in Xylazine use. Describe the current trends that detail the scope and the extent of the Xylazine issue. PRESENTERS Jason Bienert, RN, CWCN Josh Esrick, MPP   DRUG ENFORCEMENT AGENCY (DEA) GUEST:  Gail Poirier Section Chief, Strategic Intelligence Section (NIT) Jaclyn Iera Program Manager, Office of Forensic Sciences   SAMHSA:        Jeanne Tuono Assistant Regional Director (Region 3)      

  Expected Outcome Tool  

Use this simple chart & its key questions to map out, track and achieve your own professional development goals. For additional information, view the associated training here. 

  Use the attached fillable PDF to help develop your "why" and think of ways you can share it.     

  Webinar Description How we as prevention professionals communicate our prevention messages to our intended audience is key to our success in reaching sustainable long term substance abuse prevention outcomes.  While we have many tools at our disposal, harnessing the power of these tools to convey our prevention message and inspiring our audience to see their place at the table is how we know that our communication strategy is effective.     During this two-part series, we: Reviewed communication goals in prevention and dug into the “who” and the “what” as it relates to promoting our prevention message(s) Explored best practices for creating slides, handouts, and newsletters to support prevention efforts Identified practices that help persuade our target audience to engage in our initiative and take action   Session 2 is an opportunity to review using tools such as newsletters, handouts and slides.   Presenters  Clara McCurdy-Kirlis is a multilingual communications and project management professional and has over 15 years of experience in project development, implementation, and management. She has held lead roles in health and education instructional design for adult learners, e-learning design and delivery, higher education curricula development, and interdisciplinary project coordination. McCurdy-Kirlis has also led communities of practice (CoP) with an emphasis on facilitating dialogue in a safe space where participants can share successes, challenges, and brainstorm solutions together. Clara designs virtual and face-to-face training materials and creates tools, blogs, and informational resources for the Northeast and Caribbean Prevention Technology Transfer Center in English and Spanish.   Additional Resources  Flyer  PowerPoint

The Northeast and Caribbean Spring 2023 Newsletter is here. This issue highlights Professional Development for Prevention Professionals and our upcoming trainings. 

Amy Ronshausen is the Executive Director of both Drug Free America Foundation and Save Our Society from Drugs. Both of these national nonprofit organizations work to defeat drug legalization attempts, promote sound drug policies, and prevent drug use, abuse and addiction. Amy is passionate about reducing illegal drug use and drug prevention, coordinating grassroots advocacy campaigns, prevention summits, analyze and track state and federal drug policy legislation, and training prevention professionals at local and national conferences. www.dfaf.org (drug free America foundation)  www.saveoursociety.org (save our society from drugs) https://onechoiceprevention.org/ (One Choice) https://www.listenfirstproject.org/ (Listen First Project) https://learnaboutsam.org/ (Smart Approaches to Marijuana) https://onechancetogrowup.org/ (One Chance to Grow Up) The funder of this project, along with all other products of the Mid-America PTTC is the Substance Abuse and Mental Health Services Administration. Although funded by SAMHSA, the content of this recording does not necessarily reflect the views of SAMHSA. Did you know nearly 700 publications and digital products are available online at https://store.samhsa.gov Learn about the real risks for people who use marijuana, especially youth and young adults, and women who are pregnant or nursing. SAMHSA has online resources available at www.samhsa.gov/marijuana 

This webinar will explore common risk factors for mental health and substance use disorders.   The presentation is roughly divided into two evidence-based approaches to stigma-reduction and education:  Part 1 includes a personal testimony of co-occurring substance use disorder and mental health diagnoses.  Part 2 details the common risk factors and provides context for preventing and treating co-occurring disorders   Learning Objectives:  To compare risk factors for mental health and substance use disorders To apply research-informed approaches to preventing and/or supporting recovery from mental health and/or substance use disorders   About the Presenter:   Dr. Alex Elswick joined the Department of Family Sciences at the University of Kentucky in 2020 as an Assistant Extension Professor for Substance Use Prevention and Recovery.  He began his journey with the department as a graduate student in 2015, where he earned his Master’s and PhD and later served Family and Consumer Sciences Extension as an Extension Associate and as an Extension Specialist. Alex Elswick is a tireless advocate for people who use drugs and people with substance use disorders.  He currently serves the University of Kentucky as an Assistant Extension Professor for Substance Use Prevention and Recovery. He is a trained researcher and therapist, but most importantly, Alex is himself a person in long term recovery from the chronic disease of addiction.          

Webinar Description This event detailed successful processes for prevention professionals to communicate our prevention messages to the intended audiences and best approaches for using common communication vehicles. Learning Objectives Included: · Review communications goals in prevention · Review best practices to create and share messages that build community support for prevention initiatives · Identify strategic practices to apply in using communications tools to support prevention · Reinvigorate communications messages using a positive prevention frame   Presenter Information Kimberly Elliott is the communications director for Education Development Center's U.S. Division. She is a highly skilled nonprofit leader with 20 years of experience. Kim has been involved with all aspects of crafting meaningful and impactful messaging campaigns. She is a strategic storyteller, a book author, a highly successful grant writer, and is dedicated to helping prevention workforce professionals move our work forward by harnessing the power of words.  Ivy Jones Turner, MPA, CPS is an expert in behavioral and mental health promotion and prevention, is an experienced program leader, technical assistance (TA) specialist, applied researcher, and evaluator. Her expertise includes building the capacity of schools and organizations to research, implement, evaluate, and sustain interventions to prevent substance misuse, suicide, youth violence, and bullying, and to promote social-emotional and mental health. Ivy holds an MA in Public Administration from Harvard University’s Kennedy School of Government and is a certified specialist in prevention and conflict mediation in Massachusetts.   Additional Documents  PowerPoint  Flyer  Supplemental Resource

The May 2023 Dialogue contains articles on: Addiction: The Deadly Impact of Fentanyl: National Fentanyl Awareness Day | Mental Health: Mental Health Awareness Month | Prevention: SAMHSA’s National Prevention Week: Promoting Health and Wellness | ORN: Make Possibilities a Reality | Regional Spotlight: ORN Xylazine Regional Summit Additional sections include behavioral health observances, virtual training and webinar events, Region 3 news, and new resources. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated on the first Tuesday of each month. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter.  Sign up to receive the Dialogue in your mailbox. 

Use of the veterinary drug xylazine is having a profound impact on the health of those who use illicit substances across the United States. Originally developed by the pharmaceutical company Bayer in 1962 as a large animal sedative containing a muscle relaxant with analgesic properties, xylazine was never intended for human consumption and therefore identified as a non-classified drug by the Food and Drug Administration (FDA), requiring only a veterinarian’s prescription. In humans, xylazine acts on the central nervous system and may cause drowsiness, slowed breathing, decreased heart rate, lowered blood pressure, and even amnesia. So when did this veterinary drug enter into the street drug supply chain, and how did it get there?

The National Hispanic and Latino PTTC are excited to announce the translation of SAMHSA’s Strategic Prevention Framework guide from English to Spanish. The original English and translated Spanish versions are available to download.

 

In this Issue:   National Alcohol Awareness Month Resources for the Prevention Professional National Women's Health Week, May 14-20 How to Find Help Epi Corner: Substance Use Disorders in People with Disabilities What's Happening Around the Region? Webinar: Substance Misuse Among Students with Disabilities, A 2-part series, April 26 and May 18 Free Online Courses through HealtheKnowledge SAMHSA's National Prevention Week, May 7-13

  This webinar will cover the products typically utilized in vape devices, such as THC. We will also discuss the components and constituents and associated health risks. Finally, we will discuss available some resources for helping people quit smoking or vaping.   Learning Objectives: Participants will increase their understanding of vape function and product usage. Participants will be able to restate the risks of vaping after the event. Participants will map policy concerns about vaping for their state/region. Participants will be able to find and recommend resources for their clients.   About the Presenter: Dr. Mary Martinasek is an Associate Professor in Public Health at the University of Tampa. She is also a registered respiratory therapist, a certified asthma educator, a tobacco treatment and health education specialist. Mary’s research is focused on hookah smoking and vaping electronic nicotine delivery devices; however, she also conducted a systematic review on the respiratory effects of inhalational marijuana. Her recent manuscripts have focused on the relationship of Adverse Childhood Experiences as predictors of vaping and tobacco use, asthma and vaping, and social marketing campaigns for hookah reduction.  

The March 2023 (Part 2) Dialogue contains articles on: Mental Health: Celebrating Women in Medicine  |  Regional Spotlight: Sean's House. Additional sections include behavioral health observances, virtual training and webinar events, Region 3 news, and new resources. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated on the first Tuesday of each month. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter.  Sign up to receive the Dialogue in your mailbox.